Cargando…
Vitreous estrogen levels in patients with an idiopathic macular hole
PURPOSE: Estrogen, a female hormone, activates collagenase and might be associated with the pathogenesis of vitreoretinal collagen fiber disease. The purpose of the present study was to investigate the vitreous levels of estrone (E1) and estradiol (E2) in subjects with an idiopathic macular hole (IM...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376308/ https://www.ncbi.nlm.nih.gov/pubmed/25848205 http://dx.doi.org/10.2147/OPTH.S80754 |
_version_ | 1782363720979054592 |
---|---|
author | Inokuchi, Naoki Ikeda, Tsunehiko Nakamura, Kimitoshi Morishita, Seita Fukumoto, Masanori Kida, Teruyo Oku, Hidehiro |
author_facet | Inokuchi, Naoki Ikeda, Tsunehiko Nakamura, Kimitoshi Morishita, Seita Fukumoto, Masanori Kida, Teruyo Oku, Hidehiro |
author_sort | Inokuchi, Naoki |
collection | PubMed |
description | PURPOSE: Estrogen, a female hormone, activates collagenase and might be associated with the pathogenesis of vitreoretinal collagen fiber disease. The purpose of the present study was to investigate the vitreous levels of estrone (E1) and estradiol (E2) in subjects with an idiopathic macular hole (IMH). METHODS: Vitreous samples were obtained from ten female patients with an IMH and from nine female patients with other retinal diseases (six with rhegmatogenous retinal detachment and three with age-related macular degeneration) as a control at the time of vitreous surgery. E1 and E2 levels in the vitreous samples were then determined using the Coat-A-Count(®) Estradiol Radioimmunoassay (RIA) Kit and the DSL-70 Estrone RIA Kit, respectively. RESULTS: The mean vitreous levels of E1 and E2 in the subjects with IMH were 1.83±2.00 pg/mL and 7.03±2.97 pg/mL, respectively, whereas in the control subjects they were 2.42±1.25 pg/mL and 4.90±2.90 pg/mL, respectively. Thus, the vitreous E2 levels in the subjects with IMH were significantly higher than in the controls (P<0.05). CONCLUSION: The findings of this study suggest that E2 might be associated with the pathogenesis of IMH, but further investigation is needed to elucidate that association. |
format | Online Article Text |
id | pubmed-4376308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43763082015-04-06 Vitreous estrogen levels in patients with an idiopathic macular hole Inokuchi, Naoki Ikeda, Tsunehiko Nakamura, Kimitoshi Morishita, Seita Fukumoto, Masanori Kida, Teruyo Oku, Hidehiro Clin Ophthalmol Original Research PURPOSE: Estrogen, a female hormone, activates collagenase and might be associated with the pathogenesis of vitreoretinal collagen fiber disease. The purpose of the present study was to investigate the vitreous levels of estrone (E1) and estradiol (E2) in subjects with an idiopathic macular hole (IMH). METHODS: Vitreous samples were obtained from ten female patients with an IMH and from nine female patients with other retinal diseases (six with rhegmatogenous retinal detachment and three with age-related macular degeneration) as a control at the time of vitreous surgery. E1 and E2 levels in the vitreous samples were then determined using the Coat-A-Count(®) Estradiol Radioimmunoassay (RIA) Kit and the DSL-70 Estrone RIA Kit, respectively. RESULTS: The mean vitreous levels of E1 and E2 in the subjects with IMH were 1.83±2.00 pg/mL and 7.03±2.97 pg/mL, respectively, whereas in the control subjects they were 2.42±1.25 pg/mL and 4.90±2.90 pg/mL, respectively. Thus, the vitreous E2 levels in the subjects with IMH were significantly higher than in the controls (P<0.05). CONCLUSION: The findings of this study suggest that E2 might be associated with the pathogenesis of IMH, but further investigation is needed to elucidate that association. Dove Medical Press 2015-03-20 /pmc/articles/PMC4376308/ /pubmed/25848205 http://dx.doi.org/10.2147/OPTH.S80754 Text en © 2015 Inokuchi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Inokuchi, Naoki Ikeda, Tsunehiko Nakamura, Kimitoshi Morishita, Seita Fukumoto, Masanori Kida, Teruyo Oku, Hidehiro Vitreous estrogen levels in patients with an idiopathic macular hole |
title | Vitreous estrogen levels in patients with an idiopathic macular hole |
title_full | Vitreous estrogen levels in patients with an idiopathic macular hole |
title_fullStr | Vitreous estrogen levels in patients with an idiopathic macular hole |
title_full_unstemmed | Vitreous estrogen levels in patients with an idiopathic macular hole |
title_short | Vitreous estrogen levels in patients with an idiopathic macular hole |
title_sort | vitreous estrogen levels in patients with an idiopathic macular hole |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376308/ https://www.ncbi.nlm.nih.gov/pubmed/25848205 http://dx.doi.org/10.2147/OPTH.S80754 |
work_keys_str_mv | AT inokuchinaoki vitreousestrogenlevelsinpatientswithanidiopathicmacularhole AT ikedatsunehiko vitreousestrogenlevelsinpatientswithanidiopathicmacularhole AT nakamurakimitoshi vitreousestrogenlevelsinpatientswithanidiopathicmacularhole AT morishitaseita vitreousestrogenlevelsinpatientswithanidiopathicmacularhole AT fukumotomasanori vitreousestrogenlevelsinpatientswithanidiopathicmacularhole AT kidateruyo vitreousestrogenlevelsinpatientswithanidiopathicmacularhole AT okuhidehiro vitreousestrogenlevelsinpatientswithanidiopathicmacularhole |